A major advance in understanding how quinidine depresses maximum upstroke velocity (V mai ) is the Hondeghem-Katzung mathematical model which incorporates voltage-independent rate constants for binding to and unbinding from resting, open, and inactive Na channels, and a voltage shift of -40 mV for the Hodgkin-Huxley h-kinetics of quinidine-associated Na channels. Using a double microelectrode voltage clamp technique to control transmembrane voltage and apply conditioning pulses, we found that quinidine blockade increased as transmembrane voltage became more positive in the range -60 to +40 mV, and that the rate of quinidine dissociation increased as transmembrane voltage became more negative in the range -60 to -140 mV. The relationship of V max to transmembrane voltage obtained at drive cycles from 500 msec to 20 seconds conformed to the model modified to include voltage-dependent rate constants without the postulated -40-mV shift for quinidine-associated channels. Thus binding of quinidine to inactive Na channels and unbinding from resting channels are both voltage-dependent and can explain frequency and voltage dependent actions of quinidine on V max without any voltage shift for quinidine-associated channels. (Ore Res 50: [369][370][371][372][373][374][375][376] 1982) A CHARACTERISTIC common to most antiarrhythmic drugs is depression of phase 0 of the cardiac action potential. Depression of Vmax by quinidine has been found to be dependent upon both frequency of stimulation and transmembrane voltage (Weidmann, 1955b; Johnson and McKinnon, 1957; Heistracher, 1971) . A major advance in our understanding of how quinidine acts to depress V max has been the "modulated receptor hypothesis" model proposed by Hondeghem and Katzung (1977a , 1977b , 1980 see also Hille, 1977; Courtney, 1980) (Fig. 1 ). This model explains depression of phase 0 upstroke velocity in terms of binding and unbinding of quinidine to the membrane sodium channel, thereby providing insight into the mechanisms of antiarrhythmic action. The Hondeghem-Katzung rate constants for binding and unbinding of quinidine from the sodium channel are not directly voltage-dependent but, instead, are dependent on the configuration of the sodium channel (modulated receptor hypothesis). Transmembrane voltage changes affect quinidine binding by changing the sodium channel among resting, open, and inactive configurations.
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Methods
Ovine hearts were obtained at a slaughterhouse and transported to the laboratory in an insulated jug containing iced Tyrode's solution equilibrated with 95% C>2-5% CO 2 . Excised 2-mm fiber segments were stored in Tyrode's solution at 20-24°C until studied. The composition of the Tyrode's solution in mmol/liter was: NaCl, 137; NaHCQj, 12; NaH 2 PO 4 , 1.8; dextrose, 5.5; CaCl 2 , 2.4; MgCI 2 , 0.5; and KC1, 4.0. Quinidine sulfate (Aldrich) was added to the test solution to provide a final concentration of 10 mg/liter of base. The tissue chamber was perfused at 6-10 ml/min, and experimental measurements were begun 30 minutes after beginning quinidine superfusion. Bath temperature was * In the model (Fig. 1) , kiandkpare in sec 'M ', and hand 1 K are in sec~\ We used a quinidine concentration of 10 mg/liter (3 X 10 " 5 M) and express binding rate constants as ki [Qj and kulQ] where units are sec''. Hondeghem and Katzung, 1980; Courtney, 1980; Hille, 1977 maintained at 36 °C. Glass capillary microelectrodes for recording transmembrane voltage were filled with 3 M KG. Microelectrodes for passing current were filled with 2 M potassium citrate. The voltage clamp circuit, display and photographic apparatus, bath, heating, and circulating equipment have been described previously Bigger, 1975, 1976) .
To study quinidine association with closed inactive sodium channels, we used a voltage clamp to apply depolarized conditioning pulses more positive than -40 mV (where sodium channels are in the closed and inactive state), and varied either conditioning voltage or conditioning pulse interval (see Figs. 2 and 3) . At the end of the conditioning pulse, the fiber was clamped back to the holding voltage of -80 mV for 200 msec, long enough to enable quinidinefree sodium channels to reactivate fully, but short enough so that negligible dissociation of quinidine from blocked channels occurred (Hondeghem and Katzung, 1977a , 1977b , 1980 vide infra) . At the end of the 200-msec holding interval, we opened the voltage clamp with an electronic relay, stimulated the fiber with a bipolar external electrode or an intracellular current pulse, and measured V ma i of the action potential upstroke (Fig. 4) . The conditioning pulseaction potential sequence was repeated every 20 seconds, allowing adequate time at the holding voltage of -80 mV between each sequence for recovery of Vma* from quinidineinduced depression.
To study recovery from quinidine blockade of closed resting channels with the voltage clamp, we varied recovery time at a repolarized voltage after a fixed depolarized conditioning pulse (Figs. 5 and 6). To study the relationship between V M , and activation voltage (transmembrane voltage from which action potential phase 0 is elicited), we clamped the fiber at a desired holding voltage. After 20 seconds, we then disconnected the voltage clamp for 20 msec with an electronic relay, immediately stimulated the membrane with a 0.1-msec rectangular pulse via external electrodes (within 1 msec after disconnecting the voltage clamp), and measured V ma , of the action potential upstroke Following a Z-second conditioning pulse, an action potential is elicited (arrow) and Vm^ is measured. As the conditioning pulse voltage becomes more positive, V^t, shows more depression, reflecting enhanced blockade of inactive channels by quinidine.
obtained. We then changed the holding clamp voltage and repeated the procedure. This was repeated for voltages from -60 to -140 mV to obtain the steady state V ma5 -activation voltage relationship. To obtain this relationship for 500msec cycles, we similarly measured V ma , of action potential upstrokes elicited every 500 msec instead of every 20 seconds. After changing holding clamp voltage, we did not measure V mM until V max reached its steady state value. Data were used from experiments where impalements were maintained throughout control, quinidine, and washout. Data are mean ± SD. First order regressions were fit by the method of least squares. Statistical significance of differences between control and quinidine data was determined by the t-test for paired samples (Snedecor and Cochran, 1978) .
Results

Effects of Quinidine on the Purkinje Fiber Action Potential
Based on preliminary dose-ranging experiments, we chose to study a quinidine concentration of 10 mg/liter. Depression of V max of action potential phase 0 ranges from negligible (when the membrane is hyperpolarized) to marked (when preceded by a depolarized conditioning pulse) at this concentration; thus we could examine drug binding to and unbinding from a majority of the membrane sodium channels (vide infra). During superfusion of 11 Purkinje fiber preparations with quinidine 10 mg/liter, action potentials elicited at a 1000-msec cycle showed depolarization of membrane activation voltage (voltage from which phase 0 begins) from -85.2 ± 6.2 mV to -78.6 ± 7.0 mV; depolarization of maximum diastolic volt- Figure 5 . Only the slow phase of recovery is shown. When a more depolarized conditioning pulse is used, more Vmax is blocked (i.e., the y-intercept becomes larger at the expense of the rapidly recovering fraction seen in Figure 5 ) but recovery kinetics are unchanged. Thus the fraction of quinidine-blocked channels can be increased with a more depolarized conditioning pulse, but, upon repolarization to VH, quinidine dissociates from these channels with the same kinetics, independent of the magnitude of quinidine blockade.
repolarization from 313 ± 88 msec to 166 ± 117 msec (all changes significant at P < 0.05); and slowing of terminal repolarization. There was no significant change in the magnitude of phase 4 depolarization.
Voltage Dependence of Quinidine Binding to Inactivated Sodium Channels
To determine blocking of inactive sodium channels by quinidine, we measured Vmax after a depolarized conditioning pulse of variable duration. Depression of V m ax increased in an exponential fashion as the duration of the conditioning voltage clamp increased (Fig-2) .
To determine the voltage dependence of the inactivation of V max by quinidine during conditioning pulses, we varied the magnitude of the conditioning pulse (Fig. 3) . There was little voltage-dependent depression of V m ax when conditioning pulses were more negative than -60 mV. At conditioning pulse voltages more positive than -60 mV, there was a progressive increase in the magnitude of V ma x depression. Derivation of the rate constants for binding with (ki[Q]) and unbinding from (h) sodium channels from these data is given in the Discussion. (ki[Q] is the binding rate constant in sec" 1 for a quinidine concentration of 10 mg/liter, or 3 X 10~5 M.)
Voltage Dependence of Quinidine Dissociation from Resting Sodium Channels
We evaluated recovery from quinidine-induced V max depression by plotting V max of action potentials against the recovery interval following a fixed depolarized conditioning pulse. Removal of inactivation is obtained by plotting against recovery time the difference between V ma x measured during recovery and peak Vmax- Figure 5 shows removal of inactivation at -80 mV following a 2-second conditioning pulse at +20 mV, plotted on a semilogarithmic scale. In all quinidine experiments, a rapid phase of V max recovery, with kinetics comparable to recovery in control solution, preceded a slow phase of recovery, representing recovery of V max from quinidine depression (Fig. 5 ). The fraction of Vmax blocked by quinidine during the conditioning pulse could be increased by making the pulse either longer or more depolarized, but the first order kinetics of the recovery process following the conditioning pulse were unaltered (Fig.  6) . Derivation of the rate constant for dissociation of quinidine from resting channels (1R) from these data is given in the Discussion.
Quinidine-induced Voltage Shifts
To test the hypothesis that quinidine shifts the voltage dependence of the magnitude of Vmax, we determined the relationship of Vmax to activation voltage. First, we found that clamping for longer than 20 seconds prior to an action potential upstroke during exposure to quinidine did not result in further recovery of Vmax, so we concluded that the steady state Vmax-activation voltage relationship can be obtained A 20-second drive cycle is long enough for V max to recover to a peak steady state value in quinidine, with the curve shifted negative by a few mV compared to control. Peak V mlLr of phase 0 elicited from very negative voltages is the same for control and quinidine at a drive cycle of 20 seconds. However, when drive cycle is shortened to 500 msec, Vmo* in quinidine is shifted markedly downward and to more negative voltages, reflecting incomplete recovery of V ma x between action potential upstrokes. The dashed line represents quinidine's effect at a drive cycle of 500 msec predicted by the Hondeghem-Katzung model, and includes an inflection (double sigmoid configuration), which results from the AV of about -40 in Figure 1 . The experimentally determined shape of the V max -activation voltage relationship in quinidine displays a smooth sigmoid configuration, suggesting that AV (in Figure 1) is 0.
at a drive cycle of 20 seconds (Fig. 7) . In 12 steady state V m ax-activation voltage experiments, quinidine minimally shifted the voltage at half-maximal V max (V h ) from -64.2 ± 7.3 mV to -67.0 ± 7.1 mV (P < ' 0.02) at a 20-second drive cycle. The peak V ma x obtainable was not diminished by quinidine: hyperpo-Iarization to -90 mV or more negative at a drive cycle of 20 seconds restored the peak V max in quinidine (556 ± 219 V/sec) to control values (562 ± 203 V/sec, difference not significant). Because the Hondeghem-Katzung model (Fig. 1 ) uses rate constants for drug binding which are not voltage-dependent, the model is obliged to account for more rapid reactivation of Vmax at more negative voltages by postulating a voltage shift of about -40 mV for the Hodgkin-Huxley ah of quinidine-associated channels. In view of our finding that rate constants for quinidine binding and unbinding are dependent upon transmembrane voltage, we wondered whether the Hondeghem-Katzung mathematical model actually required the postulated -40 mV voltage shift for Hodgkin-Huxley kinetics of drug-associated channels. To evaluate whether such a voltage shift for the Hodkin-Huxley kinetics of quinidineblocked channels actually exists, we tested the Hondeghem-Katzung model prediction (which results from the postulated voltage shift) that the relationship between V max and activation voltage exhibits an inflection, or double sigmoid configuration, as drive cycle is shortened. We found that abbreviation of the drive cycle to 500 msec during exposure to quinidine produced a marked shift of the V max -activation voltage relationship downward and to more negative voltages (Fig. 7) . We did not observe the predicted inflection, or double sigmoid shape, of the V max -activation voltage relationship in any of 15 experiments, and we were unable to restore peak V max to control values at a 500-msec cycle even with membrane hyperpolarization to -140 mV prior to eliciting an action potential upstroke (Fig. 7) .
Discussion
Voltage Dependence of Quinidine Binding to Inactivated Sodium Channels
To obtain ki[Q] and h, the rate constants for blocking and unblocking inactive sodium channels (Hodgkin-Huxley h gate closed) by quinidine, we used the time course for and the steady state value of depression of V m ax by quinidine during sustained depolarized pulses. The time course of blocking the inactivated sodium channel by quinidine in Figure 2 is approximated well by an exponential fit. If I' represents the fraction of inactive sodium channels associated with quinidine, we can express the change in quinidine-associated channels as:
where li is the rate constant for dissociation of quinidine from quinidine-associated inactive channels and V is transmembrane voltage. Prior to a depolarized pulse, we held transmembrane voltage adequately negative to ensure that I' = 0 at t = 0. Therefore, during a sustained depolarized pulse, the amount of block is given by (cf. Courtney, 1980) :
where Is., is the steady state fraction of quinidine-373 associated inactive channels at the test voltage, and:
The term (ki(V)[Q] + li(V)) in Equation 2 is the slope of the exponential regression in Figure 2 . The value of Us in Equation 3 is the difference between V max at zero time and at "infinite" time (asymptotic value of the exponential regression) in Figure 2 . We used Equations 2 and 3 to obtain ki [Q] and h at different test voltages (Fig. 8) . Figure 8 also includes the Hondeghem-Katzung model values for ki [Q] and l h in order to highlight the differences between the model values and experimental data.
Voltage Dependence of Quinidine Dissociation from Resting Sodium Channels
To obtain IR, the rate constant for unblocking the resting sodium channels (Hodgkin-Huxley h gate open) by quinidine, we used the time course for recovery of V max from quinidine depression. Recovery, plotted as removal of quinidine block in Figure  5 , is approximated well by an exponential process. If R' represents the fraction of resting sodium channels associated with quinidine, we can express the change in quinidine-associated channels as:
where kft(V)[Q] is the rate constant for blocking of resting channels by quinidine. Since recovery of V max from quinidine depression proceeds to completion if enough time elapses (except possibly in the narrow voltage range of the steep portion of the V ma x-activation voltage relationship), IR must be much larger than kR [Q] , and the last term in Equation 4 becomes negligibly small. The solution to Equation 4 then becomes R' = (e" lRt )
where R' C ond is the fraction of quinidine-associated channels after the depolarized conditioning pulse (y- axis intercept for slow recovery of V max in Figs. 5 and 6) and 1R is the only unknown. The values for 1 R obtained in this way are given in Figure 9 . Figure 9 includes the Hondeghem-Katzung model value for 1R, to permit comparison of the model value to actual experimental data.
Quinidine-Induced Voltage Shifts
In the Hondeghem-Katzung mathematical model (1977a, 1977b, 1980) , quinidine causes a voltage shift of -40 mV in the voltage dependence of the Hodgkin-Huxley ah rate constant for recovery of quinidineassociated channels from I' to R' (Fig. 1) , but not for recovery of quinidine-free channels from I to R. The postulated voltage shift predicts that the single sigmoid curve of the V ma x-activation voltage relationship obtained at long drive cycles will develop an inflection (dashed line in Fig. 7) when drive cycle is shorted to 500 msec, and that V ma x will attain its peak value with hyperpolarization to -140 mV. We did not find an inflection (double sigmoid configuration) in the V maiactivation voltage relationship at drive cycles as short as 500 msec, and Vmax at 500-msec cycles never reached peak V max even at -140 mV (e.g., Fig. 7) . These findings are not consistent with the -40-mV voltage shift postulated by Hondeghem and Katzung for quinidine-associated channels, but can be explained fully by voltage dependence of the rate constant, 1R, for quinidine unbinding from resting channels.
The V max -activation voltage relationship at a 20second drive cycle (e.g., Fig. 7) showed a mean quinidine-induced shift of -2.8 mV on the voltage axis which could not be decreased by increasing drive cycle beyond 20 seconds. The most likely cause for this small voltage shift is that the association rate constant for quinidine binding to resting channels, kR [Q] , is significant in the voltage range of the steep portion of the Vmax-activation voltage relationship. Our results predict that KD, the equilibrium dissociation constant, is voltage-dependent, and the value of kR[Q] at any particular voltage will depend on the relative magnitude of KD at that voltage compared to the concentration of quinidine;used. Therefore, only at less negative voltages (-60 to -75 mV) , where the concentration of quinidine we used (10 mg/liter, or 30 HM) approaches the value of KD will kR[Q] be significant with respect to 1R. Another possible explanation for the small negative shift of the steady state Vmax-activation voltage relationship by quinidine is a "charge shielding" action of quinidine at the cell membrane, affecting all membrane sodium channels regardless of association with quinidine.
Significance of the Present Experiments
Implicit in our experiments is the assumption that V max is a measure of sodium current and sodium conductance. Although cardiac electrophysiologists have used V ma x as an indirect measure of sodium conductance since Weidmann's study in 1955, this has been and is an area of considerable controversy. Theoretical arguments based on computer modeling of action potential currents have led to both support (Hondeghem, 1978; Walton and Fozzard, 1979) and opposition (Hunter et al., 1975; Cohen and Strichartz, 1977; Strichartz and Cohen, 1978) to the concept that V max is a valid measure of sodium current and sodium conductance. Bean et al. (1981) and Cohen et al. (1981) have suggested that, under certain conditions in rabbit Purkinje fibers, V m ax is a non-linear measure of sodium conductance. Preliminary investigations in our own laboratory show that some of the theoretical objections to the use of V max as a measure of sodium conductance are not significant limitations under certain experimental conditions (Coromilas et al., 1981) . Whereas the validity of V ma x as a linear measure of peak sodium current and conductance must still be considered an unsettled issue, there is little doubt that V ma x is generated by the early inward transient current and provides valuable indirect information about changes in this current. Chen et al. (1975) and Chen and Gettes (1976) concluded that quinidine did not alter the recovery kinetics of V ma x, but that quinidine did depress V ma x in a voltage-dependent manner which was more marked at higher drive rates. Chen and Gettes (1976) felt the most likely explanation for enhanced depression of Vmax at higher drive rates was depression of the ATPase-dependent Na-K pump by quinidine, resulting in a decrease in the transmembrane sodium gradient, which became more marked as the drive rate (and sodium entry into the cell) increased. However, both Hondeghem and Katzung (1977) and we have shown that quinidine does slow recovery kinetics of Vmax. Also, we found that the most intense quinidine-induced depression of Vmax occurred at the most positive conditioning voltages, where the driving force for entry of sodium into the cell is the least. Therefore, it is not necessary to postulate fatigue of the Na-K pump (and intracellular Na accumulation) to account for depression of V mM by quinidine. Our data on recovery from depression of V ma x by quinidine are most consistent with time-and voltagedependent unblocking of membrane sodium channels by quinidine.
The rate constants for blocking and unblocking of inactive channels by quinidine in the transmembrane voltage range of the action potential plateau suggests that little binding of quinidine occurs during the plateau. Association of quinidine to membrane sodium channels therefore must occur predominantly during phase 0 (Hondeghem and Katzung, 1980) . Our data suggest that antiarrhythmic efficacy (which is associated with depression of Vmax) may be more pronounced as heart rate increases and recovery time decreases. Likewise, a high quinidine concentration may be safe at a slow heart rate but may become toxic at more rapid rates. Quinidine-toxic depression of V max should be reversed best by maneuvers to hyperpolarize the cell membrane and to avoid rapid heart rates. Further, although there is only minor association of quinidine with inactive sodium channels during the action potential plateau, abbreviation of the action potential should nonetheless antagonize quinidine-induced depression of Vmax by virtue of the resultant increase in recovery time after repolarization.
The existing Hondeghem-Katzung model (Hondeghem and Katzung, 1980) for depression of V max by quinidine utilizes the modulated receptor hypothesis (Hille, 1977; Hondeghem and Katzung, 1977a, 1977b; Fig. 1) . According to this model, a sodium channel in any of the resting, open, or inactive states can combine with quinidine and thereby be blocked. Each channel state (resting, open, and inactive) has characteristic rate constants for quinidine binding and unbinding; these rate constants do not vary with transmembrane voltage. The present experiments indicate that binding of quinidine to inactive sodium channels and unbinding of quinidine from resting sodium channels are, in fact, strongly voltage-dependent. Thus, transmembrane voltage modulates either the access of quinidine to its channel-blocking position or else the kinetics of the actual association of quinidine with its channel-blocking site (receptor). Since the degree of openness of inactive channels should decrease with more depolarized voltages (i.e., the steady state value of Hodgkin-Huxley m 3 h should decrease), we doubt that the increase in ki[Q] at positive transmembrane voltages reflects enhanced access of quinidine to its binding site through the channels themselves. Instead, we favor either voltage-enhanced association of quinidine with its blocking site, perhaps through a voltagedependent change in channel geometry at the inner surface of the membrane, or a voltage-enhanced movement of quinidine across non-channel portions of the membrane to the cell interior. In deciding between these two possibilities, the kinetics of quin-idine blockage are helpful. Since extracellular quinidine is relatively constant, we would expect a voltageenhanced movement of quinidine into the cell to exhibit zero-order kinetics. However, the enhancement of block by depolarized voltages exhibits an exponential time course (see Fig. 2 ). This evidence favors a voltage-modulated association of quinidine with its blocking site.
In summary, the present experiments show that binding of quinidine to inactive channels and unbinding from resting sodium channels are voltage-dependent. Further, our data indicate that there is no significant shift for the Hodgkin-Huxley h-kinetics of quinidine-associated channels. These suggested changes for the Hondeghem-Katzung model result in a more accurate and more powerful model for the interaction of quinidine with the cardiac Purkinje fiber membrane sodium channel.
